Market Cap 788.01M
Revenue (ttm) 0.00
Net Income (ttm) -49.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 191,400
Avg Vol 246,340
Day's Range N/A - N/A
Shares Out 27.54M
Stochastic %K 76%
Beta 0.43
Analysts Strong Sell
Price Target $44.14

Latest News on LENZ

LENZ Therapeutics: Freedom From Reading Glasses

Apr 7, 2025, 8:00 AM EDT - 19 days ago

LENZ Therapeutics: Freedom From Reading Glasses


LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 27, 2025, 5:33 PM EDT - 4 weeks ago

LENZ Therapeutics Stock Is Attractive Before PDUFA


LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 8:09 PM EDT - 5 weeks ago

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript


LENZ Therapeutics to Host Commercial Day on April 15, 2025

Mar 3, 2025, 8:00 AM EST - 7 weeks ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025


LENZ Therapeutics, Inc. (LENZ) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 11:43 AM EST - 6 months ago

LENZ Therapeutics, Inc. (LENZ) Q3 2024 Earnings Call Transcript


Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 6 months ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS


LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 30, 2024, 8:00 AM EDT - 8 months ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks


LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 7:43 PM EDT - 9 months ago

LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript


LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 14, 2024, 4:05 PM EDT - 9 months ago

LENZ Therapeutics Reports Second Quarter 2024 Financial Results